POSTER SESSION IV
Tuesday, March 23, 2010   —  1:00 PM - 4:30 PM
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GENITOURINARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
87 Utility of Uroplakin and PAX-2 Immunohistochemistry in the Diagnosis of Primary Adenocarcinoma of the Urinary Bladder (1024)
H Ye, X Wu, DE Hansel, J Melamed, JI Epstein - New York University School of Medicine, New York, NY; Cleveland Clinic, Cleveland, OH; The Johns Hopkins Hospital, Baltimore, MD 		Add
88 Hepatocyte Nuclear Factor-1 Beta Expression in Clear Cell Adenocarcinomas of the Bladder and Urethra (875)
PB Illei, J Epstein, M Herawi, R Sharma, F Brimo - Johns Hopkins Medical Institutions, Baltimore, MD; Wayne State University, Detroit, MI 		Add
89 Adenocarcinoma of the Urinary Bladder: Value of Cell Cycle Biomarkers (889)
E King, R Youssef, W Kabbani, A Mosbah, H Abol-Enein, M Ghoniem, Y Lotan, P Kapur - UT Southwestern Medical Center, Dallas, TX; Urology & Nephrology Center Mansoura University, Mansoura, Egypt 		Add
90 Glandular Atypia in a Background of Cystitis Glandularis: An Immunohistochemical and LCM Based Molecular Analysis (984)
S Srivastava, Y Benedict, SY Chin, T Muliana, SS Omar, MS Tellez, M Teh - National University of Singapore and National University Hospital, Singapore, Singapore 		Add
91 Outcomes Associated with Carcinoma In Situ (pTis) and No Residual Disease (pT0) on Radical Cystectomy (1016)
KE Watts, DE Hansel - Cleveland Clinic, Cleveland, OH 		Add
92 Validation of Pathologic Substaging of "Deeply Invasive/Locally Aggressive" Urinary Bladder Cancers: A Data from the National Cancer Data Base (939)
GP Paner, K Pollitt, A Stewart, B Bochner, J McKiernan, Members of AJCC GU Task Force, SS Chang, MB Amin - Loyola University Medical Center, Maywood, IL; American College of Surgeons, Chicago, IL; Cedars-Sinai Medical Center, Los Angeles, CA 		Add
93 Pitfalls in the Use of Smoothelin To Identify Muscularis Propria Invasion by Urothelial Carcinoma (921)
H Miyamoto, RB Sharma, PB Illei, JI Epstein - The Johns Hopkins Hospital, Baltimore 		Add
94 Impact of Second Review of Bladder Biopsies and Transurethral Bladder Tumor Resections with Smoothelin Staining on Pathologic Stage (821)
M Cox, M Quick, W Winham, T Kelly, N Gokden - University of Arkansas for Medical Sciences, Little Rock, AR 		Add
95 Papillary Urothelial Hyperplasia of the Bladder: Relationship to Urothelial Carcinoma (953)
N Readal, JI Epstein - The Johns Hopkins Hospital, Baltimore 		Add
96 Prognostic Significance of the 2004 WHO/ISUP Classification for Prediction of Recurrence, Progression and Cancer-Specific Mortality of Non-Muscle-Invasive Urothelial Tumors of the Urinary Bladder: A Clinicopathologic Study of 1515 Cases (937)
CC Pan, HJ Yu, CH Sun - Taipei Veterans General Hospital, Taipei, Taiwan 		Add
97 Interobserver Reproducibility in the Diagnosis of Invasive Micropapillary Carcinoma of the Genitourinary Tract among Expert Urologic Pathologists (965)
AR Sangoi, AH Beck, MB Amin, L Cheng, JI Epstein, DE Hansel, KA Iczkowski, JY Ro, A Lopez-Beltran, E Oliva, GP Paner, VE Reuter, RB Shah, SS Shen, P Tamboli, JK McKenney - Stanford, Stanford, CA; Cedars-Sinai, Los Angeles, CA; U Indiana, Indianapolis, IN; Johns Hopkins, Baltimore, MD; Cleveland Clinic, Cleveland, OH; U Colorado, Aurora, CO; Methodist, Houston, TX; Unit Anatomic Pathology, Cordoba, Spain; Massachusetts General Hospital, Boston, MA; Northwestern, Chicago, IL; Memorial Sloan Kettering, New York, NY; U Michigan, Ann Arbor, MI; UT MD Anderson, Houston, TX 		Add
98 Correlation between HER2 Gene Amplification and Protein Expression in Micropapillary Urothelial Carcinoma (816)
CB Ching, MB Amin, R Tubbs, DE Hansel - The Cleveland Clinic, Cleveland, OH; Cedars-Sinai Medical Center, Los Angeles, CA 		Add
99 Variant Histologic Differentiation in Urothelial Carcinoma Is Frequently Under-Recognized and Documented in Community Practice (894)
LP Kunju, RB Shah - University of Michigan, Ann Arbor, MI 		Add
100 Histopathology and Response of Bladder Cancer to Neoadjuvant Therapy (831)
LJ Eisengart, SM Rohan, G MacVicar, XJ Yang - Northwestern University, Chicago, IL 		Add
101 Non-Glandular Carcinomas of the Urachus (938)
GP Paner, TJ Sebo, RE Jimenez - Loyola University Medical Center, Maywood, IL; Mayo Clinic, Rochester, MN 		Add
102 Epithelial and Mesenchymal Urinary Tract Lesions in Patients ≤30 Years of Age (819)
ST Chuang, M Zhou, C Magi-Galluzzi, DE Hansel - H Lee Moffitt Cancer Center, Tampa, FL; Cleveland Clinic, Cleveland, OH 		Add
103 Ectopic Prostatic Tissue: Histogenesis and Histopathologic Characteristics (862)
SK Halat, JN Eble, DJ Grignon, S Lacy, R Montironi, GT MacLennan, A Lopez-Beltran, PH Tan, LA Baldridge, L Cheng - Indiana University, Indianapolis, IN; Polytechnic University of the Marche Region (Ancona), Ancona, Italy; Case Western Reserve University, Cleveland, OH; Crodoba University, Cordoba, Spain; Singapore General Hospital, Singapore, Singapore 		Add
104 Retrospective Analysis of Prostatic Adenocarcinomas Scored as Gleason Grade 1 as a Primary or Secondary Grade in Transurethral Resection or Radical Prostatectomy Specimens (880)
RE Jimenez, JP Reynolds, JC Cheville - Mayo Clinic, Rochester, MN 		Add
105 Should Saved Interval Sections of Prostate Needle Biopsy Specimens Be Examined Microscopically? (887)
EH Kerr, VL Dailey, WE Grizzle, O Hameed - University of Alabama at Birmingham, Birmingham, AL 		Add
106 Extraprostatic Extension of Prostatic Adenocarcinoma on Needle Core Biopsy: Report of 72 Cases with Clinical Follow-Up (920)
JS Miller, Y Chen, BD Robinson, F Brimo, JI Epstein - Johns Hopkins Hospital, Baltimore 		Add
107 Does Perineural Invasion on Prostate Biopsy Predict Adverse Prostatectomy Outcomes? (906)
S Loeb, JI Epstein, EB Humphreys, PC Walsh - The Johns Hopkins Hospital, Baltimore 		Add
108 The Novel Immunohistochemical p75/p63 Antibody Cocktail Is a Reliable Basal Cell Marker in Prostatic Core Needle Biopsies (926)
SM Moran, O O'Brien, F O'Connell, D McCrae, TJ Browne - Cork University Hospital, Cork, Ireland 		Add
109 Isolated Single Core High Grade Prostatic Adenocarcinoma Is Associated with Increased Likelihood of Extraprostatic Extension, Seminal Vesicle Invasion, Positive Surgical Margins and Lymphovascular Invasion at Radical Prostatectomy (841)
DA Fajardo, AW Partin, M Eisenberger, TL DeWeese, GJ Netto - Johns Hopkins University, Baltimore, MD 		Add
110 Skeletal Muscle Involvement by Limited Gleason Score 3+3=6 Cancer on Needle Biopsy Is Not Associated with Adverse Findings at Radical Prostatectomy (1025)
H Ye, JI Epstein - The Johns Hopkins Hospital, Baltimore 		Add
111 Atypical Glands Suspicious for Carcinoma Followed by the Diagnosis of Carcinoma on Prostate Needle Biopsy: Findings at Radical Prostatectomy (812)
YB Chen, PM Pierorazio, JI Epstein - The Johns Hopkins Hospital, Baltimore 		Add
112 Various Morphometric Measurements of Cancer in Needle Prostatic Biopsies: Which Is Predictive of Pathologic Stage and PSA Failure Post-Surgery? (948)
MM Quintal, A Billis, L Meirelles, LLL Freitas, LA Magna, U Ferreira - School of Medicine, University of Campinas (Unicamp), Campinas, Brazil 		Add
113 Quantification of Cancer in Prostate Needle Biopsies: AMACR and Digital Image Analysis (944)
V Parimi, LJ Eisengart, XJ Yang - Northwestern University, Chicago, IL 		Add
114 Pre-Operative Predictors of Adverse Prostatectomy Outcome. Correlation of 389 12-Core Needle Biopsy Results with Subsequent Prostatectomy Data (893)
ON Kryvenko, M Diaz-Insua, M Ramineni, M Menon, NS Gupta - Henry Ford Hospital, Detroit, MI 		Add
115 CD44 Promoter Methylation and Prostate Cancer Progression - Analysis of Microdissected Samples (866)
JC Hanson, O Akhtar, LG Adams, FC Eberle, WM Linehan, PA Pinto, DC Edelman, MR Emmert-Buck, J Rodriguez-Canales - National Cancer Institute, Bethesda, MD 		Add
116 DNA Methylation of HOXD3 as a Marker of Prostate Cancer Progression (1004)
TH Van der Kwast, K Kron, V Pethe, L Briollais, B Bapat - University Health Network and University of Toronto, Toronto, Canada; Mount Sinai Hospital, Toronto, Canada 		Add
117 Assessment of Circulating Tumor Cells in Low Tumor Volume Prostate Cancer Patients (850)
B Furusato, A Ali, PO Ts'o, ZP Lum, S Srivastava, S Brassell, DG McLeod, IA Sesterhenn - Armed Forces Institute of Pathology, Washington, DC; Uniformed Services University of the Health Sciences, Bethesda, MD; Walter Reed Army Medical Center, Washington, DC; CCC Diagnostics, LLC, Baltimore, MD 		Add
118 Robotic Prostatectomy Surgical Time Correlates with Specimen Autolysis (924)
AP Modi, AP Patel, GN Box, DS Sharp, A Shabsigh, R Abaza, DL Zynger - The Ohio State Medical Center, Columbus, OH 		Add
119 Prostate Cancer Biobanking Protocol for the Cancer Genome Altas and High Quality Clinical Care (835)
R Esgueva, R Kim, M Shevchuk, AK Tewari, MA Rubin - Weill Cornell Medical College, New York, NY 		Add
120 Amplification of Ribosomal RNA Gene Loci in Human Prostate Cancer (1034)
Q Zheng, S Yegnasubramanian, AM De Marzo - Johns Hopkins, Baltimore, MD 		Add
121 Integrative Molecular Profiling of Castration Resistant Prostate Cancer (981)
K Sircar, D Cogdell, J Dhillon, H Huang, L Hu, N Navone, R Katz, A Khanna, TA Bismar, IH Koumakpayi, F Saad, AG Aprikian, FA Monzon, P Troncoso, W Zhang - MD Anderson Cancer Center, Houston, TX; UT Arlington, Arlington, TX; University of Calgary, Calgary, AB, Canada; Universite de Montreal, Montreal, QC, Canada; McGill University, Montreal, QC, Canada; The Methodist Hospital Research Institute, Houston, TX 		Add
122 Quantitative Digital Analysis of Histologic Features of Prostatic Adenocarcinoma (945)
Y Peng, Y Jiang, L Eisengart, S-T Chuang, FH Straus, XJ Yang - University of Chicago, Chicago, IL; Northwestern University, Chicago, IL 		Add
123 Differential MicroRNA Expression in Localised and Advanced Prostatic Adenocarcinoma (783)
C Barrett, P Smyth, A Murphy, B Loftus, O Sheils, JJ O'Leary - Trinity College Dublin, Dublin, Ireland; Adelaide & Meath Hospital, Dublin, Ireland 		Add
124 RNA Yields and RT-PCR Gene Expression Profiles Obtained from Manual-Microdissected Fixed Paraffin-Embedded Prostate Cancer Needle Core Biopsies (911)
C Magi-Galluzzi, CL Millward, T Maddala, DB Cherbavaz, A Chen, SM Falzarano, M Lee, FL Baehner, EA Klein - Cleveland Clinic, Cleveland, OH; Genomic Health, Inc, Redwood City, CA 		Add
125 Validation of Molecular Markers of Aggressiveness in Prostate Cancer (881)
A Johnson, N Rosener, A Rizzardi, R Isaksson Vogel, G Metzger, S Schmechel - University of Minnesota, Minneapolis, MN; University of Minnesota, Minnesota, MN 		Add